X. Liao

P. Jänne, G. Freeman, F. Hodi, 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Tyrosine kinase B receptor and BDNF expression in ovarian cancers - Effect on cell migration, angiogenesis and clinical outcome.

E. Wong, A. Cheung, X. Liao, 2009, Cancer letters.

Tumour CD274 (PD-L1) expression and T cells in colorectal cancer

Mingyang Song, Yin Cao, Reiko Nishihara, 2016, Gut.

Tumor PDCD1LG2 (PD-L2) Expression and the Lymphocytic Reaction to Colorectal Cancer

Yan Shi, G. Freeman, A. Bass, 2017, Cancer Immunology Research.

Estrogen Receptor Subtypes in Ovarian Cancer: A Clinical Correlation

H. Ngan, A. Cheung, K. Chan, 2008, Obstetrics and gynecology.

No evidence for interference of h&e staining in DNA testing: usefulness of DNA extraction from H&E-stained archival tissue sections.

S. Ogino, Z. Qian, C. Fuchs, 2012, American journal of clinical pathology.

LncRNA CASC7 inhibits the progression of glioma via regulating Wnt/β-catenin signaling pathway.

X. Liao, Meng-Yi Huang, X. Gong, 2019, Pathology, research and practice.

Immune Profiling of Adenoid Cystic Carcinoma: PD-L2 Expression and Associations with Tumor-Infiltrating Lymphocytes

G. Freeman, P. Hammerman, F. Hodi, 2016, Cancer Immunology Research.

Survival Benefit of Exercise Differs by Tumor IRS1 Expression Status in Colorectal Cancer

Yin Cao, Reiko Nishihara, Shuji Ogino, 2016, Annals of Surgical Oncology.

Physical Activity, Tumor PTGS2 Expression, and Survival in Patients with Colorectal Cancer

J. Meyerhardt, E. Giovannucci, S. Ogino, 2013, Cancer Epidemiology, Biomarkers & Prevention.

P63 Expression in Gestational Trophoblastic Disease: Correlation With Proliferation and Apoptotic Dynamics

M. K. Siu, H. Ngan, A. Cheung, 2009, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

PD-L1 Antibodies to Its Cytoplasmic Domain Most Clearly Delineate Cell Membranes in Immunohistochemical Staining of Tumor Cells

G. Freeman, S. Signoretti, F. Hodi, 2015, Cancer Immunology Research.

SMO Expression in Colorectal Cancer: Associations with Clinical, Pathological, and Molecular Features

Reiko Nishihara, Shuji Ogino, Andrew T. Chan, 2014, Annals of Surgical Oncology.

Predictive and prognostic analysis of PIK3CA mutation in stage III colon cancer intergroup trial.

D. Spiegelman, J. Meyerhardt, A. Benson, 2013, Journal of the National Cancer Institute.

Expression of Programmed Cell Death 1 Ligand 2 (PD-L2) Is a Distinguishing Feature of Primary Mediastinal (Thymic) Large B-cell Lymphoma and Associated With PDCD1LG2 Copy Gain

G. Pinkus, M. Shipp, G. Freeman, 2014, The American journal of surgical pathology.

Imaging , Diagnosis , Prognosis Speci fi c Mutations in KRAS Codons 12 and 13 , and Patient Prognosis in 1075 BRAF Wild-Type Colorectal Cancers

J. Meyerhardt, S. Ogino, R. Nishihara, 2012 .

Anti-CTLA-4 based therapy elicits humoral immunity to galectin-3 in patients with metastatic melanoma

A. Giobbie-Hurder, F. Hodi, S. Rodig, 2018, Oncoimmunology.

Combined Anti-VEGF and Anti–CTLA-4 Therapy Elicits Humoral Immunity to Galectin-1 Which Is Associated with Favorable Clinical Outcomes

A. Giobbie-Hurder, M. Shipp, G. Dranoff, 2017, Cancer Immunology Research.

Overexpression of long noncoding RNA PCAT-1 is a novel biomarker of poor prognosis in patients with colorectal cancer

Weihua Jia, Yuanbin Chen, Xiao-song Ge, 2013, Medical Oncology.

VEGF Neutralization Plus CTLA-4 Blockade Alters Soluble and Cellular Factors Associated with Enhancing Lymphocyte Infiltration and Humoral Recognition in Melanoma

A. Giobbie-Hurder, F. Hodi, S. Rodig, 2016, Cancer Immunology Research.

Expression of PD-1 and Its Ligands, PD-L1 and PD-L2, in Smokers and Never Smokers with KRAS-Mutant Lung Cancer

P. Jänne, F. Hodi, D. Jackman, 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Epithelial PD-L2 Expression Marks Barrett's Esophagus and Esophageal Adenocarcinoma

Michael S. Goldberg, J. Davison, G. Freeman, 2015, Cancer Immunology Research.

Expression of Programmed Cell Death 1 Ligand 2 (PD-L2) Is a Distinguishing Feature of Primary Mediastinal (Thymic) Large B-cell Lymphoma and Associated With PDCD1LG2 Copy Gain

G. Pinkus, M. Shipp, S. Rodig, 2014, The American journal of surgical pathology.

Microsatellite instability and BRAF mutation testing in colorectal cancer prognostication.

Jeanne Shen, J. Meyerhardt, S. Ogino, 2013, Journal of the National Cancer Institute.

Microsatellite Instability and Braf Mutation Testing in Colorectal Cancer Prognostication Braf Mutation in Colorectal Cancer Is Associated with Microsatellite Instability (msi) through Its Relationship with High-level Cpg Island Methylator Phenotype (cimp) and Mlh1 Promoter Methylation. Msi and Braf

J. Meyerhardt, S. Ogino, P. Lochhead, 2022 .

A prospective study of duration of smoking cessation and colorectal cancer risk by epigenetics-related tumor classification.

E. Giovannucci, I. Kawachi, S. Ogino, 2013, American journal of epidemiology.

Hypermethylation of RAS effector related genes and DNA methyltransferase 1 expression in endometrial carcinogenesis

M. K. Siu, E. Wong, H. Ngan, 2008, International journal of cancer.

Epigenetic Alteration of the Metallothionein 1E Gene in Human Endometrial Carcinomas

H. Ngan, A. Cheung, D. Chan, 2009, Tumor Biology.

Epithelial PD-L 2 Expression Marks Barrett ' s Esophagus and Esophageal Adenocarcinoma

Michael S. Goldberg, J. Davison, G. Freeman, 2015 .

Loss of Programmed cell death 4 (Pdcd4) associates with the progression of ovarian cancer

A. Cheung, Thomas H. Leung, X. Liao, 2009, Molecular Cancer.